Averion, India CRO Apothecaries To Expand Core Oncology Competencies And Global Presence

Averion International Corp, a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology has signed a non-exclusive agreement with Apothecaries Ltd of New Delhi, India, a full-service CRO with a focus on oncology.

Under the terms of the agreement, the two companies will jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies.

"Averion and our Millennix Oncology specialty service brand will obtain access to leading clinical sites in India with competent staffing and access to a significant patient population, further building on our strategy to expand our global oncology development programs," said Gene D Resnick, MD, Averion Chief Medical Officer.

Apothecaries has conducted a multitude of early- and late-stage trials in indications including breast, head and neck, and cervical cancers. "We are pleased to partner our extensive capabilities in India with Averion and its solid reputation for offering clinical trials that are executed to the highest standard," said Brijesh Regal, MPharm, Apothecaries CEO.